Literature DB >> 18924376

Gonadal alterations in male whitefish Coregonus fatioi: no evidence for genetic damage reducing viability in early life stages.

Davnah Urbach1, Adrian Britschgi, Alain Jacob, David Bittner, Daniel Bernet, Thomas Wahli, Nigel G Yoccoz, Claus Wedekind.   

Abstract

In recent years, numerous cases of morphological gonadal alterations in fish have been recorded throughout the world and across a wide range of species. In the whitefish Coregonus fatioi from the pre-alpine Lake Thun (Switzerland), the frequency of gonadal alterations is particularly high and the variety of alteration types large. Little is known about the proximal causes and the direct consequences of these morphological features on population persistence. In particular, the potential for the observed alterations to be the phenotypic expression of reduced genetic quality has not yet been addressed. In this study, we used offspring survival during embryogenesis as a proximate indicator of male genetic quality and tested whether the presence of gonadal alterations in males is an indicator of reduced quality. Embryos resulted from in vitro fertilizations of gametes from 126 males and females. We found no significant correlation between embryo survival and gonadal alteration in adults. Our findings suggest that in C. fatioi of Lake Thun, alterations in gonad morphology are not a phenotypic expression of variation in genetic quality.

Entities:  

Mesh:

Year:  2008        PMID: 18924376     DOI: 10.3354/dao01952

Source DB:  PubMed          Journal:  Dis Aquat Organ        ISSN: 0177-5103            Impact factor:   1.802


  1 in total

1.  Sex differentiation in grayling (Salmonidae) goes through an all-male stage and is delayed in genetic males who instead grow faster.

Authors:  Diane Maitre; Oliver M Selmoni; Anshu Uppal; Lucas Marques da Cunha; Laetitia G E Wilkins; Julien Roux; Kenyon B Mobley; Isabelle Castro; Susanne Knörr; Marc Robinson-Rechavi; Claus Wedekind
Journal:  Sci Rep       Date:  2017-11-03       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.